Short answer
Perspective Therapeutics, Inc. (CATX) filed its Q1 2026 10-Q quarterly report on May 11, 2026 for the quarter ended Mar 31, 2026.
Q1 2026 key financials · XBRL
- Net income
- −$26M
- −44.1% YoY
- EPS (diluted)
- −$0.25
- +0.0% YoY
Source: XBRL data from the Perspective Therapeutics, Inc. (CATX) Q1 2026 10-Q on SEC EDGAR. USD.
Perspective Therapeutics, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No risk-factors section provided in the submitted excerpt
- No newly added, updated, regulatory, operational, competitive, market, or financial risks identifiable
- Excerpt covers Items 2–6 and signatures, not Item 1A Risk Factors
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Perspective Therapeutics, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.